A patient admitted with left pyelonephritis, hypotension and metabolic acidosis who developed acute coronary syndrome before placement of a left double‑J ureteral stent—what is the appropriate next management?

Management of Acute Coronary Syndrome in a Patient with Septic Shock from Pyelonephritis

The acute coronary syndrome takes immediate priority and requires urgent coronary angiography within 2 hours, while simultaneously managing the septic shock with vasopressors, antibiotics, and source control—the DJ stent placement should proceed emergently as part of sepsis source control, ideally immediately after or concurrent with coronary intervention. 1

Immediate Management Algorithm (First 2 Hours)

Step 1: Stabilize Hemodynamics While Preparing for Cardiac Catheterization

• Initiate vasopressor support (norepinephrine first-line) to maintain adequate coronary perfusion pressure while avoiding excessive myocardial oxygen demand 1
• Start intravenous beta-blockers cautiously only after hemodynamic stabilization; in the setting of hypotension and shock, delay beta-blocker initiation until the patient is stable 2
• Administer intravenous nitroglycerin for ongoing ischemia if systolic blood pressure >90 mmHg, titrating carefully to avoid worsening hypotension 2
• Correct metabolic acidosis with judicious fluid resuscitation; sodium bicarbonate may be considered if pH ≤7.20, though evidence for mortality benefit is lacking 3

Step 2: Initiate Dual Antiplatelet Therapy Immediately

• Load with aspirin 325 mg (non-enteric coated) immediately 4, 5
• Load with a P2Y12 inhibitor before angiography: ticagrelor 180 mg or clopidogrel 600 mg (prasugrel contraindicated if anatomy unknown and CABG may be needed) 4, 5
• Avoid upstream glycoprotein IIb/IIIa inhibitors until coronary anatomy is known 6

Step 3: Proceed to Immediate Invasive Strategy (<2 Hours)

This patient meets very-high-risk criteria requiring immediate coronary angiography due to hemodynamic instability 1, 7:

• Hemodynamic instability/cardiogenic shock is a Class I, Level C indication for immediate invasive strategy 1
• Renal insufficiency (from obstructive pyelonephritis) is an intermediate-risk criterion that would otherwise mandate early invasive strategy within 72 hours, but the hypotension upgrades this to immediate 1
• Metabolic acidosis with acute heart failure constitutes very high-risk features 1

Step 4: Revascularization Strategy During Catheterization

• Perform PCI of the culprit lesion only if multivessel disease is present; immediate multivessel PCI is not recommended in cardiogenic shock 7, 5
• Consider mechanical circulatory support (microaxial flow pump) if cardiogenic shock persists despite initial management, though this increases bleeding and vascular complications 5
• Use radial access if feasible to reduce bleeding complications, though femoral access may be necessary if shock requires mechanical support 5
• Employ intracoronary imaging (IVUS or OCT) to guide PCI in complex lesions 5

Concurrent Sepsis Management

Source Control Cannot Be Delayed

The DJ stent placement must proceed urgently as obstructive pyelonephritis with septic shock requires immediate drainage 1:

• Optimal timing: Place DJ stent immediately after coronary intervention (within 2-4 hours of presentation) or consider concurrent procedures if institutional capabilities allow 1
• The presence of ACS does not contraindicate urgent urological intervention—both conditions are life-threatening and require immediate treatment 1
• Antiplatelet therapy increases bleeding risk but is non-negotiable for ACS; communicate closely with urology regarding bleeding risk and consider transfusion threshold of hemoglobin <8 g/dL (or <10 g/dL may be reasonable in ACS) 5

Antibiotic and Supportive Care

• Broad-spectrum antibiotics should already be initiated for pyelonephritis with septic shock
• Aggressive fluid resuscitation while monitoring for pulmonary edema given ACS
• Vasopressor support to maintain MAP ≥65 mmHg for adequate organ perfusion

Critical Pitfalls to Avoid

Do not delay coronary angiography for DJ stent placement—the ACS with hemodynamic instability is immediately life-threatening and requires intervention within 2 hours 1. However, do not delay DJ stent beyond 4-6 hours as obstructive pyelonephritis with septic shock also requires urgent source control.

Do not withhold antiplatelet therapy due to upcoming urological procedure—the mortality benefit of appropriate ACS treatment outweighs bleeding risk 4, 5. Coordinate with urology regarding meticulous hemostasis during stent placement.

Do not administer beta-blockers in the acute phase if the patient remains hypotensive—this can worsen cardiogenic shock 2. Wait until hemodynamic stability is achieved.

Do not perform immediate multivessel PCI if shock is present—culprit-lesion-only PCI with possible staged revascularization reduces mortality in cardiogenic shock 7, 5.

Post-Procedure Management

• Continue dual antiplatelet therapy for minimum 12 months 4, 5
• Initiate high-intensity statin (atorvastatin 80 mg or rosuvastatin 40 mg) 8, 9
• Add ACE inhibitor once hemodynamically stable, particularly given renal dysfunction 2
• Beta-blocker once shock resolves and patient is euvolemic 2, 4
• Proton pump inhibitor given high bleeding risk from dual antiplatelet therapy and critical illness 5